Skip to content
← Holders

MPM Bioimpact LLC

What MPM Bioimpact LLC reported holding on Form 13F for the quarter ended Sep 30, 2026.

CIK 1687078 · Filed Nov 16, 2026

Positions
37
Reported value
$1.3B
Opened
37
Closed
37
Other managers included
0

Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR

Quarters on file

  1. Sep 30, 2025$610.9M
    40 positions
  2. Dec 31, 2025$874M
    38 positions
  3. Mar 31, 2026$1.3B
    41 positions
  4. Jun 30, 2026$1.6B
    37 positions
  5. Sep 30, 2026$1.3B
    37 positions
SecuritySharesChangeValueOf portfolio
CGEMCullinan Therapeutics, Inc.
9.7MNew$149.2M11.1%
AKTSAktis Oncology, Inc.
4.8MNew$94.2M7%
TVTXTravere Therapeutics, Inc.
1.1MNew$64.1M4.8%
EWTXEdgewise Therapeutics, Inc.
1.6MNew$64M4.7%
DYNDyne Therapeutics, Inc.
3.2MNew$51.7M3.8%
CORTCorcept Therapeutics Inc
422KNew$48.6M3.6%
CORTCorcept Therapeutics IncPut option
422KNew$48.6M3.6%
RLAYRelay Therapeutics, Inc.
2.4MNew$42.8M3.2%
TRVITrevi Therapeutics, Inc.
3MNew$42.7M3.2%
IOVAIovance Biotherapeutics, Inc.
2.8MNew$42M3.1%
LQDALiquidia Corp
1.3MNew$40.6M3%
NTRANatera, Inc.
90.6KNew$37.4M2.8%
URGNUroGen Pharma Ltd.
909.7KNew$37M2.7%
IMCRImmunocore Holdings plc
1.2MNew$36.4M2.7%
DBVTDBV Technologies S.A.
3MNew$35.8M2.7%
TSHATaysha Gene Therapies, Inc.
7.3MNew$35.4M2.6%
ABVXAbivax S.A.
328.4KNew$32.5M2.4%
VIRVir Biotechnology, Inc.
2.8MNew$31.4M2.3%
ANLAdlai Nortye Group Ltd.
2MNew$31.3M2.3%
VSTMVerastem, Inc.
3.9MNew$31M2.3%
QUREuniQure N.V.
1.2MNew$29M2.2%
ODTXOdyssey Therapeutics, Inc.
1.3MNew$28.6M2.1%
TARSTarsus Pharmaceuticals, Inc.
352.7KNew$27.7M2.1%
PVLAPalvella Therapeutics, Inc.
197.6KNew$27.3M2%
ACRSAclaris Therapeutics, Inc.
5.2MNew$27.2M2%
ORKAOruka Therapeutics, Inc.
300KNew$25M1.9%
ORICOric Pharmaceuticals, Inc.
1.8MNew$24.5M1.8%
STOKStoke Therapeutics, Inc.
925.1KNew$24.1M1.8%
BLTEBelite Bio, Inc
133.4KNew$22.7M1.7%
NGNENeurogene Inc.
771.8KNew$21.5M1.6%
ZURAZura Bio Ltd
4.4MNew$18.5M1.4%
ANNXAnnexon, Inc.
4.3MNew$18.1M1.3%
GLUEMonte Rosa Therapeutics, Inc.
1.1MNew$13.4M1%
BIOABioAge Labs, Inc.
1.9MNew$13.2M1%
CRBPCorbus Pharmaceuticals Holdings, Inc.
1.7MNew$11.4M0.8%
DRUGBright Minds Biosciences Inc.
195.7KNew$9.7M0.7%
TRAXFirst Tracks Biotherapeutics, Inc.
254.4KNew$9M0.7%